Commerce Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Sell |
7,490
-853
| -10% | -$380K | 0.02% | 390 |
|
|
2025
Q1 | $4.04M | Sell |
8,343
-295
| -3% | -$143K | 0.03% | 348 |
|
|
2024
Q4 | $3.48M | Buy |
8,638
+1,195
| +16% | +$481K | 0.02% | 383 |
|
|
2024
Q3 | $3.46M | Buy |
7,443
+775
| +12% | +$360K | 0.02% | 397 |
|
|
2024
Q2 | $3.13M | Buy |
6,668
+8
| +0.1% | +$3.75K | 0.02% | 399 |
|
|
2024
Q1 | $2.78M | Sell |
6,660
-364
| -5% | -$152K | 0.02% | 431 |
|
|
2023
Q4 | $2.86M | Buy |
7,024
+89
| +1% | +$36.2K | 0.02% | 417 |
|
|
2023
Q3 | $2.41M | Sell |
6,935
-116
| -2% | -$40.3K | 0.02% | 421 |
|
|
2023
Q2 | $2.48M | Buy |
7,051
+289
| +4% | +$102K | 0.02% | 417 |
|
|
2023
Q1 | $2.13M | Sell |
6,762
-451
| -6% | -$142K | 0.02% | 429 |
|
|
2022
Q4 | $2.08M | Buy |
7,213
+472
| +7% | +$136K | 0.02% | 429 |
|
|
2022
Q3 | $1.95M | Buy |
6,741
+72
| +1% | +$20.8K | 0.02% | 441 |
|
|
2022
Q2 | $1.88M | Sell |
6,669
-98
| -1% | -$27.6K | 0.02% | 448 |
|
|
2022
Q1 | $1.77M | Buy |
6,767
+1,378
| +26% | +$360K | 0.01% | 483 |
|
|
2021
Q4 | $1.18M | Buy |
5,389
+464
| +9% | +$102K | 0.01% | 585 |
|
|
2021
Q3 | $893K | Sell |
4,925
-294
| -6% | -$53.3K | 0.01% | 649 |
|
|
2021
Q2 | $1.05M | Sell |
5,219
-319
| -6% | -$64.3K | 0.01% | 596 |
|
|
2021
Q1 | $1.19M | Buy |
5,538
+363
| +7% | +$78K | 0.01% | 539 |
|
|
2020
Q4 | $1.22M | Sell |
5,175
-314
| -6% | -$74.3K | 0.01% | 514 |
|
|
2020
Q3 | $1.49M | Buy |
5,489
+547
| +11% | +$149K | 0.01% | 439 |
|
|
2020
Q2 | $1.44M | Sell |
4,942
-821
| -14% | -$238K | 0.01% | 447 |
|
|
2020
Q1 | $1.37M | Buy |
5,763
+1,506
| +35% | +$358K | 0.02% | 403 |
|
|
2019
Q4 | $932K | Buy |
4,257
+531
| +14% | +$116K | 0.01% | 492 |
|
|
2019
Q3 | $631K | Buy |
3,726
+147
| +4% | +$24.9K | 0.01% | 567 |
|
|
2019
Q2 | $657K | Buy |
3,579
+104
| +3% | +$19.1K | 0.01% | 531 |
|
|
2019
Q1 | $639K | Buy |
3,475
+93
| +3% | +$17.1K | 0.01% | 503 |
|
|
2018
Q4 | $561K | Buy |
3,382
+964
| +40% | +$160K | 0.01% | 500 |
|
|
2018
Q3 | $466K | Buy |
2,418
+40
| +2% | +$7.71K | 0.01% | 611 |
|
|
2018
Q2 | $404K | Buy |
2,378
+366
| +18% | +$62.2K | 0.01% | 638 |
|
|
2018
Q1 | $328K | Buy |
2,012
+75
| +4% | +$12.2K | ﹤0.01% | 692 |
|
|
2017
Q4 | $290K | Buy |
1,937
+235
| +14% | +$35.2K | ﹤0.01% | 727 |
|
|
2017
Q3 | $259K | Buy |
1,702
+100
| +6% | +$15.2K | ﹤0.01% | 738 |
|
|
2017
Q2 | $206K | Buy |
+1,602
| New | +$206K | ﹤0.01% | 789 |
|